[Therapy of the lower respiratory tract infections in aged patients. Clinical experience with ceftriaxone using a single daily dose].
Sixty-seven elderly patients affected by acute or chronic pulmonary pathologies were treated parenterally with ceftriaxone in a single dose of 2 g/day. A deterioration of the bacterial analysis of expectorate during or at the end of therapy was observed in 92.5% of patients; a reduced bacteria count was found in one case; and no clinical or bacterial effects were observed in 3 cases. No adverse effects or changes in the main hematochemical parameters were reported.
Balzarotti
C
C
Istituto di Scienze Medico-Chirurgiche, Università di Milano.
Banfi
P
P
Ferrante
L
L
Zennaro
M
M
Fumagalli
G
G
D000367:Age Factors; D000368:Aged; D001419:Bacteria / Q000187:drug effects; D002443:Ceftriaxone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D002443:Ceftriaxone
Terapia delle infezioni delle basse vie respiratorie nel paziente anziano. Esperienza clinica con ceftriaxone in monodose giornaliera.